• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C反应蛋白与鳞状细胞癌抗原联合用于预测食管鳞状细胞癌患者术后预后

Combination of c-reactive protein and squamous cell carcinoma antigen in predicting postoperative prognosis for patients with squamous cell carcinoma of the esophagus.

作者信息

Feng Ji-Feng, Chen Sheng, Yang Xun

机构信息

Department of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou 310022, China.

Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, Hangzhou 310022, China.

出版信息

Oncotarget. 2017 Jun 27;8(38):63132-63139. doi: 10.18632/oncotarget.18667. eCollection 2017 Sep 8.

DOI:10.18632/oncotarget.18667
PMID:28968977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5609909/
Abstract

BACKGROUND

We initially proposed a useful and novel prognostic model, named CCS [Combination of c-reactive protein (CRP) and squamous cell carcinoma antigen (SCC)], for predicting the postoperative survival in patients with esophageal squamous cell carcinoma (ESCC).

METHODS

Two hundred and fifty-two patients with resectable ESCC were included in this retrospective study. A logistic regression was performed and yielded a logistic equation. The CCS was calculated by the combined CRP and SCC. The optimal cut-off value for CCS was evaluated by X-tile program. Univariate and multivariate analyses were used to evaluate the predictive factors. In addition, a novel nomogram model was also performed to predict the prognosis for patients with ESCC.

RESULTS

In the current study, CCS was calculated as CRP+6.33 SCC according to the logistic equation. The optimal cut-off value was 15.8 for CCS according to the X-tile program. Kaplan-Meier analyses demonstrated that high CCS group had a significantly poor 5-year cancer-specific survival (CSS) than low CCS group (10.3% vs. 47.3%, <0.001). According to multivariate analyses, CCS ( =0.004), but not CRP ( =0.466) or SCC ( =0.926), was an independent prognostic factor. A nomogram could be more accuracy for CSS (Harrell's c-index: 0.70).

CONCLUSION

The CCS is a usefull and independent predictive factor in patients with ESCC.

摘要

背景

我们最初提出了一种有用且新颖的预后模型,名为CCS[C反应蛋白(CRP)与鳞状细胞癌抗原(SCC)的组合],用于预测食管鳞状细胞癌(ESCC)患者的术后生存率。

方法

本回顾性研究纳入了252例可切除的ESCC患者。进行逻辑回归分析并得出一个逻辑方程。通过联合CRP和SCC计算CCS。使用X-tile程序评估CCS的最佳临界值。采用单因素和多因素分析来评估预测因素。此外,还构建了一种新颖的列线图模型来预测ESCC患者的预后。

结果

在本研究中,根据逻辑方程,CCS计算为CRP + 6.33 SCC。根据X-tile程序,CCS的最佳临界值为15.8。Kaplan-Meier分析表明,高CCS组的5年癌症特异性生存率(CSS)显著低于低CCS组(10.3%对47.3%,<0.001)。多因素分析显示,CCS(=0.004)是独立的预后因素,而CRP(=0.466)或SCC(=0.926)不是。列线图对CSS的预测可能更准确(Harrell's c指数:0.70)。

结论

CCS是ESCC患者有用的独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a749/5609909/e19e946b8282/oncotarget-08-63132-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a749/5609909/30fcfeb9cf6a/oncotarget-08-63132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a749/5609909/ea5299289ed3/oncotarget-08-63132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a749/5609909/2652ba1de826/oncotarget-08-63132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a749/5609909/e19e946b8282/oncotarget-08-63132-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a749/5609909/30fcfeb9cf6a/oncotarget-08-63132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a749/5609909/ea5299289ed3/oncotarget-08-63132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a749/5609909/2652ba1de826/oncotarget-08-63132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a749/5609909/e19e946b8282/oncotarget-08-63132-g004.jpg

相似文献

1
Combination of c-reactive protein and squamous cell carcinoma antigen in predicting postoperative prognosis for patients with squamous cell carcinoma of the esophagus.C反应蛋白与鳞状细胞癌抗原联合用于预测食管鳞状细胞癌患者术后预后
Oncotarget. 2017 Jun 27;8(38):63132-63139. doi: 10.18632/oncotarget.18667. eCollection 2017 Sep 8.
2
A novel inflammation-based prognostic score for patients with esophageal squamous cell carcinoma: the c-reactive protein/prognostic nutritional index ratio.一种基于炎症的食管癌鳞状细胞癌患者预后评分:C反应蛋白/预后营养指数比值
Oncotarget. 2016 Sep 20;7(38):62123-62132. doi: 10.18632/oncotarget.11389.
3
A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma: neutrophil lymphocyte ratio/albumin ratio.一种用于食管鳞状细胞癌患者的基于炎症的新型预后指数:中性粒细胞淋巴细胞比率/白蛋白比率。
Oncotarget. 2017 Oct 20;8(61):103535-103542. doi: 10.18632/oncotarget.21989. eCollection 2017 Nov 28.
4
C-Reactive Protein to Prealbumin Ratio (CPR): A Novel Inflammatory-Nutritional Prognostic Factor for Predicting Cancer-Specific Survival (CSS) and Overall Survival (OS) in Patients with Resectable Esophageal Squamous Cell Carcinoma.C反应蛋白与前白蛋白比值(CPR):预测可切除食管鳞状细胞癌患者癌症特异性生存(CSS)和总生存(OS)的新型炎症-营养预后因素
J Oncol. 2019 Jul 14;2019:4359103. doi: 10.1155/2019/4359103. eCollection 2019.
5
The combination of preoperative serum C-reactive protein and carcinoembryonic antigen is a useful prognostic factor in patients with esophageal squamous cell carcinoma: a combined ROC analysis.术前血清C反应蛋白与癌胚抗原联合检测是食管鳞状细胞癌患者的一个有用预后因素:联合ROC分析
Onco Targets Ther. 2015 Apr 10;8:795-803. doi: 10.2147/OTT.S77378. eCollection 2015.
6
A Nomogram to Predict Prognostic Value of Red Cell Distribution Width in Patients with Esophageal Cancer.预测食管癌患者红细胞分布宽度预后价值的列线图
Mediators Inflamm. 2015;2015:854670. doi: 10.1155/2015/854670. Epub 2015 Oct 12.
7
A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma.一种用于预测食管鳞状细胞癌患者各种炎症生物标志物预后价值的列线图。
Am J Cancer Res. 2015 Jun 15;5(7):2180-9. eCollection 2015.
8
Prognostic Value of Plasma D-dimer in Patients with Resectable Esophageal Squamous Cell Carcinoma in China.血浆D-二聚体在中国可切除食管鳞状细胞癌患者中的预后价值
J Cancer. 2016 Jul 26;7(12):1663-1667. doi: 10.7150/jca.15216. eCollection 2016.
9
Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus.全身免疫炎症指数(SII)是食管鳞状细胞癌患者的一个有用的预后指标。
Medicine (Baltimore). 2017 Jan;96(4):e5886. doi: 10.1097/MD.0000000000005886.
10
Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.基于炎症的预后系统可预测术前血清癌胚抗原和鳞状细胞癌抗原水平正常的食管癌患者的术后生存率。
World J Surg Oncol. 2016 May 5;14:141. doi: 10.1186/s12957-016-0878-5.

引用本文的文献

1
Serum Circular FoxO3a Serves as a Novel Prognostic Biomarker in Squamous Cervical Cancer.血清环状FoxO3a作为宫颈鳞癌的一种新型预后生物标志物。
Cancer Manag Res. 2020 Apr 9;12:2531-2540. doi: 10.2147/CMAR.S243329. eCollection 2020.
2
Biological role and clinical value of miR-99a-5p in head and neck squamous cell carcinoma (HNSCC): A bioinformatics-based study.miR-99a-5p在头颈部鳞状细胞癌(HNSCC)中的生物学作用及临床价值:一项基于生物信息学的研究
FEBS Open Bio. 2018 Jun 26;8(8):1280-1298. doi: 10.1002/2211-5463.12478. eCollection 2018 Aug.

本文引用的文献

1
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.一种基于炎症的新型食管癌预后评分:C反应蛋白/白蛋白比值
BMC Cancer. 2015 May 2;15:350. doi: 10.1186/s12885-015-1379-6.
2
Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis.血清 C-反应蛋白在食管癌中的预后作用:系统评价和荟萃分析。
Ther Clin Risk Manag. 2015 Jan 21;11:89-94. doi: 10.2147/TCRM.S70954. eCollection 2015.
3
Cancer statistics, 2015.癌症统计数据,2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
4
Using SCC antigen and CRP levels as prognostic biomarkers in recurrent oral cavity squamous cell carcinoma.将鳞状细胞癌抗原(SCC抗原)和C反应蛋白(CRP)水平用作复发性口腔鳞状细胞癌的预后生物标志物。
PLoS One. 2014 Jul 25;9(7):e103265. doi: 10.1371/journal.pone.0103265. eCollection 2014.
5
ADAR1: a promising new biomarker for esophageal squamous cell carcinoma?ADAR1:食管鳞癌有前途的新生物标志物?
Expert Rev Anticancer Ther. 2014 Aug;14(8):865-8. doi: 10.1586/14737140.2014.928595. Epub 2014 Jun 13.
6
Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities.食管癌:流行病学、发病机制、分期检查及治疗方式综述
World J Gastrointest Oncol. 2014 May 15;6(5):112-20. doi: 10.4251/wjgo.v6.i5.112.
7
Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.肿瘤生物标志物预测食管癌预后的系统评价与荟萃分析。
BMC Cancer. 2013 Nov 11;13:539. doi: 10.1186/1471-2407-13-539.
8
New prognostic score for the survival of patients with esophageal squamous cell carcinoma.食管鳞状细胞癌患者生存的新预后评分
Surg Today. 2014 May;44(5):875-83. doi: 10.1007/s00595-013-0628-z. Epub 2013 Jun 20.
9
Epidemiology of esophageal cancer in Japan and China.日本和中国食管癌的流行病学。
J Epidemiol. 2013;23(4):233-42. doi: 10.2188/jea.je20120162. Epub 2013 Apr 27.
10
Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer.基于炎症的评分在接受术前化疗后手术治疗的食管癌患者中的预后价值。
Exp Ther Med. 2011 Sep;2(5):879-885. doi: 10.3892/etm.2011.308. Epub 2011 Jun 30.